secwatch.observer — SEC 8-K summary
======================================

Issuer:     NeueHealth, Inc. (—)
CIK:        0001671284
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0001671284-22-000060
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.02, 2.05, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bright Health Q3 revenue $1.6B (+51%), GAAP net loss $259M; guides FY22 Adj EBITDA loss $500-700M; restructures, new COO
--------------------------------------------------------------------------------

- Q3 revenue $1.6B (+51.3% YoY), GAAP net loss $259.4M, Adjusted EBITDA loss $82.9M.
- Enterprise Medical Cost Ratio improved to 90.6% from 103% in Q3'21.
- Lowered full-year 2022 Adjusted EBITDA loss guidance to $500-700M; revenue expected $6.8B.
- Announced restructuring: exiting Individual and Family Plan and Medicare Advantage outside California; expects workforce reduction.
- Appointed Jeff Cook as COO effective Nov 9; CEO of Bright HealthCare Michael Carson stepping down Dec 2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671284/000167128422000060/0001671284-22-000060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671284/000167128422000060/bhg-20221104.htm
  HTML page:      https://secwatch.observer/filing/0001671284-22-000060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer